Access


The information contained in this site is for healthcare professionals only.
Click ok if you are a healthcare professional.

Ok

COPDforum

Leadership

The COPDforum leadership is comprised of renowned researchers/clinicians in COPD, who have contributed significantly to the developments in this field. This global group represents some of the world's thought leaders in this area, who are prominent in respiratory publications, international and local societies and research initiatives. Click on the links below to learn more about the COPDforum leadership.

Leadership


Klaus F. Rabe

Klaus F. Rabe

MD
Germany



Place of work 

University of Kiel and Clinic Grosshansdorf, Germany.

Experience

Klaus F. Rabe is Professor of Pulmonary Medicine at the University of Kiel and Director of the Department of Pneumology at Clinic Grosshansdorf. He has been active in various fields of Respiratory Medicine worldwide, predominantly asthma, COPD and lung cancer. Professor Rabe took his final exams in medicine at Hamburg University 1983 and his clinical education began at Marienkrankenhaus Hamburg from 1983-1987 where he then spent time working at Universitätskrankenhaus Eppendorf, University of Hamburg within intensive care and endoscopic units.

Professor Rabe worked within the Pulmonary division of Krankenhaus Großhansdorf, Centre for Pneumology and Thoracic Surgery from 1988 and, in 1989, proceeded to work in Clinical Research within the Department of Thoracic Medicine, National Heart and Lung Institute, London, U.K. In 1998 Professor Rabe was nominated Professor of Medicine at the University of Leiden in the Netherlands where he was also appointed as Chairman of Pulmonology, and later in 2007 Chairman of Medicine. Into 2010 he moved back to Germany into his current position.

Professor Rabe has served on various editorial boards, was the first European Associate Editor of the American Journal of Respiratory and Critical Care Medicine and has been Chief Editor of the European Respiratory Journal until recently. His current scientific interests are related to large clinical trials in COPD and asthma, the mechanisms of airway inflammation, and the endoscopic staging of lung cancer. Professor Rabe has served on GINA and GOLD, and is a member of the German and Dutch Chest Societies, the British Pharmacological Society, the American Thoracic Society, and the president of the European Respiratory Society.

Recent publications

Bateman ED, Rabe KF, Calverley PM, Goehring UM, Brose M, Bredenbröker D, Fabbri L. Roflumilast with long-acting {beta}2 agonists for COPD: influence of exacerbation history. Eur Respir J. 2011 Jul 7

Rabe KF, Calhoun WJ, Smith N, Jimenez P. Can anti-IgE therapy prevent airway remodeling in allergic asthma? Allergy. 2011 Sep;66(9):1142–51.

Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol. 2011 May;163(1):53–67.

Rabe KF, Hiemstra PS. Theophylline for chronic obstructive pulmonary disease?....Time to move on. Am J Respir Crit Care Med. 2010 Oct 1;182(7):868–9.

Rabe KF, Decramer M, Siafakas N. The year of the lung. Lancet. 2010 Sep 4;376(9743):753–4.

Rabe KF. Roflumilast for the treatment of chronic obstructive pulmonary disease. Expert Rev Respir Med. 2010 Oct;4(5):543–55.

Rabe KF. Anticholinergic drugs for the treatment of COPD are safe... are they? Chest. 2010 Jan;137(1):1–3.

Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ; M2-124 and M2-125 study groups. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009 Aug 29;374(9691):685–94. Erratum in: Lancet. 2010 Oct 2;376(9747):1146.

Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009 Feb;33(2):227–9.

Kaptein AA, Scharloo M, Fischer MJ, Snoei L, Cameron LD, Sont JK, Rabe KF, Weinman J. Illness perceptions and COPD: an emerging field for COPD patient management. J Asthma. 2008 Oct;45(8):625–9

© Takeda, 2012 Takeda Pharmaceuticals International GmbH, Thurgauerstrasse 130, CH-8152 Glattpark-Opfikon (Zurich), Switzerland Site Map Disclaimer   Takeda
COPDforum